Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Myelodysplastic Syndromes and NRAS[original query] |
|---|
| Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias. BMC cancer 2010 10 (1): 401. Rocquain Julien, Carbuccia Nadine, Trouplin Virginie, Raynaud Stéphane, Murati Anne, Nezri Meyer, Tadrist Zoulika, Olschwang Sylviane, Vey Norbert, Birnbaum Daniel, Gelsi-Boyer Véronique, Mozziconacci Marie-Joel |
| ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia. British journal of haematology 2010 Nov 151 (4): 365-75. Gelsi-Boyer Véronique, Trouplin Virginie, Roquain Julien, Adélaïde José, Carbuccia Nadine, Esterni Benjamin, Finetti Pascal, Murati Anne, Arnoulet Christine, Zerazhi Hacène, Fezoui Hacène, Tadrist Zoulika, Nezri Meyer, Chaffanet Max, Mozziconacci Marie-Joëlle, Vey Norbert, Birnbaum Dani |
| Clinical effect of point mutations in myelodysplastic syndromes. The New England journal of medicine 2011 Jun 364 (26): 2496-506. Bejar Rafael, Stevenson Kristen, Abdel-Wahab Omar, Galili Naomi, Nilsson Björn, Garcia-Manero Guillermo, Kantarjian Hagop, Raza Azra, Levine Ross L, Neuberg Donna, Ebert Benjamin |
| Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 2012 Apr 119 (15): 3578-84. Thol Felicitas, Kade Sofia, Schlarmann Carola, Löffeld Patrick, Morgan Michael, Krauter Jürgen, Wlodarski Marcin W, Kölking Britta, Wichmann Martin, Görlich Kerstin, Göhring Gudrun, Bug Gesine, Ottmann Oliver, Niemeyer Charlotte M, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Ganser Arnold, Heuser Micha |
| The Frequency and clinical significance of IDH1 mutations in Chinese acute myeloid leukemia patients. PloS one 2013 8 (12): e83334. Guan Lixun, Gao Li, Wang Lili, Li Meng, Yin Yue, Yu Li, Gao Chun |
| Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia. American journal of hematology 2017 Mar . Patnaik Mrinal M, Barraco Daniela, Lasho Terra L, Finke Christy M, Reichard Kaaren, Hoversten Katherine P, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
| Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing. Oncotarget 2017 Oct 8 (47): 82475-82490. Xu Yuanyuan, Li Yan, Xu Qingyu, Chen Yuelong, Lv Na, Jing Yu, Dou Liping, Bo Jian, Hou Guangyuan, Guo Jing, Wang Xiuli, Wang Lili, Li Yonghui, Chen Chongjian, Yu |
| What biologic factors predict for transformation to AML? Best practice & research. Clinical haematology 2018 11 31 (4): 341-345. Bejar Rafa |
Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis.
Blood advances 2019 Nov 3 (22): 3579-3589. McGraw Kathy L, Cheng Chia-Ho, Chen Y Ann, Hou Hsin-An, Nilsson Björn, Genovese Giulio, Cluzeau Thomas, Pellagatti Andrea, Przychodzen Bartlomiej P, Mallo Mar, Arenillas Leonor, Mohamedali Azim, Adès Lionel, Sallman David A, Padron Eric, Sokol Lubomir, Moreilhon Chimene, Raynaud Sophie, Tien Hwei-Fang, Boultwood Jacqueline, Ebert Benjamin L, Sole Francesc, Fenaux Pierre, Mufti Ghulam J, Maciejewski Jaroslaw P, Kanetsky Peter A, List Alan |
| TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Leukemia 2019 Jan . Haase Detlef, Stevenson Kristen E, Neuberg Donna, Maciejewski Jaroslaw P, Nazha Aziz, Sekeres Mikkael A, Ebert Benjamin L, Garcia-Manero Guillermo, Haferlach Claudia, Haferlach Torsten, Kern Wolfgang, Ogawa Seishi, Nagata Yasunobu, Yoshida Kenichi, Graubert Timothy A, Walter Matthew J, List Alan F, Komrokji Rami S, Padron Eric, Sallman David, Papaemmanuil Elli, Campbell Peter J, Savona Michael R, Seegmiller Adam, Adès Lionel, Fenaux Pierre, Shih Lee-Yung, Bowen David, Groves Michael J, Tauro Sudhir, Fontenay Michaela, Kosmider Olivier, Bar-Natan Michal, Steensma David, Stone Richard, Heuser Michael, Thol Felicitas, Cazzola Mario, Malcovati Luca, Karsan Aly, Ganster Christina, Hellström-Lindberg Eva, Boultwood Jacqueline, Pellagatti Andrea, Santini Valeria, Quek Lynn, Vyas Paresh, Tüchler Heinz, Greenberg Peter L, Bejar Rafael, |
| Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia. Haematologica 2020 Jul . Martín-Izquierdo Marta, Abáigar María, Hernández-Sánchez Jesús M, Tamborero David, López-Cadenas Félix, Ramos Fernando, Lumbreras Eva, Madinaveitia-Ochoa Andrés, Megido Marta, Labrador Jorge, Sánchez-Real Javier, Olivier Carmen, Dávila Julio, Aguilar Carlos, Rodríguez Juan N, Martín-Nuñez Guillermo, Santos-Mínguez Sandra, Miguel-García Cristina, Benito Rocío, Díez-Campelo María, Hernández-Rivas Jesús |
| Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation. Hematology (Amsterdam, Netherlands) 2020 6 25 (1): 211-218. Wang Kai, Zhou Feng, Cai Xiaohui, Chao Hongying, Zhang Ri, Chen Suni |
| The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes. British journal of haematology 2020 11 192 (3): 589-598. Hung Sheng-Yu, Lin Chien-Chin, Hsu Chia-Lang, Yao Chi-Yuan, Wang Yu-Hung, Tsai Cheng-Hong, Hou Hsin-An, Chou Wen-Chien, Tien Hwei-Fa |
| [Predisposition and progression of myelodysplastic syndromes]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2021 5 62 (4): 278-288. Makishima Hide |
| Mutations in chronic myelomonocytic leukemia and their prognostic relevance. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 4 23 (9): 1731-1742. Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu |
| Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. Cancer medicine 2021 Feb . Yan Xuefen, Wang Lu, Jiang Lingxu, Luo Yingwan, Lin Peipei, Yang Wenli, Ren Yanling, Ma Liya, Zhou Xinping, Mei Chen, Ye Li, Xu Gaixiang, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
| Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromes. American journal of cancer research 2020 10 (12): 4476-4487. Jiang Lingxu, Wang Lu, Shen Chuying, Zhu Shuanghong, Lang Wei, Luo Yingwan, Zhang Hua, Yang Wenli, Han Yueyuan, Ma Liya, Ren Yanling, Zhou Xinping, Mei Chen, Ye Li, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
| Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes. Scientific reports 2022 4 12 (1): 5925. Maurya Nehakumari, Mohanty Purvi, Dhangar Somprakash, Panchal Purvi, Jijina Farah, Mathan S Leo Prince, Shanmukhaiah Chandrakala, Madkaikar Manisha, Vundinti Babu R |
| U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 2023 9 13 (1): 149. Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M Patna |
| [Risk factors for leukemia transformation in patients with myelodysplastic syndromes]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 1 43 (10): 818-825. Zhao S Y, Xu Z F, Qin T J, Qu S Q, Li C W, Jia Y J, Pan L J, Li B, Gao Q Y, Jiao M, Huang H J, Xiao Z |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: